An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 Feb. 10];2(S1):S33. Available from: https://skin.dermsquared.com/skin/article/view/304